Delivery Order SPE2DB20D2104-SPE2DB25FMZHM
- Not listed
- The Defense Logistics Agency awarded a $2,206.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for Priorix vials on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside contract is a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $1,514.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Priorix vials, with an ultimate completion date of June 2, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled at the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a $13,861.68 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Priorix vials. The contract is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $4,368.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the procurement of Priorix vials, with a completion date of June 25, 2025. This non-set-aside award was competitively issued and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Priorix is a measles, mumps, and rubella vaccine commonly used by military and federal healthcare systems to maintain immunization readiness across the Department of Defense....
- The Defense Logistics Agency awarded a delivery order valued at $24,753 to AmerisourceBergen Drug Corp for Priorix vials, with an ultimate completion date of July 30, 2025. This non-set-aside contract was competitively awarded on a firm fixed price basis and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Priorix is a vaccine product, consistent with AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement. This...
- The Defense Logistics Agency (DLA) awarded a $14,845.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Priorix vials, with a completion date of June 10, 2025. This is a non-set-aside competitive award executed on June 9, 2025, with performance at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- The Defense Logistics Agency awarded a $6,868.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PRIORIX vials, with a completion date of September 16, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. PRIORIX is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, making this delivery order part of the DLA's ongoing pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Priorix vials, valued at $1,009.42, with an ultimate completion date of June 2, 2025. This is a firm fixed-price delivery order issued under a competitive procurement process with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued against AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,427.10 to AmerisourceBergen Drug Corp for Priorix vials on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed price delivery order was issued without a set-aside designation and represents a competitive award under the company's broader pharmaceutical supply agreement with DLA. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a $4,950.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Priorix vials, with a completion date of September 3, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as the prime contractor on...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMZHMDelivery Order
The Defense Logistics Agency awarded a $1,694.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Priorix vials, with a completion date of September 4, 2025. This non-competitive delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Priorix is a combination vaccine used for immunization against measles, mumps, and rubella. This delivery order represents a routine pharmaceutical procurement through DLA's comprehensive global pharmaceutical support vehicle, which enables AmerisourceBergen to supply a broad range of medications, vaccines, and medical commodities to military healthcare systems worldwide. As the prime contractor on the underlying IDC, AmerisourceBergen leverages this vehicle to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with flexible and scalable pharmaceutical solutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/3/25 |